News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
482,344 Results
Type
Article (54837)
Company Profile (173)
Press Release (427325)
Multimedia
Podcasts (73)
Webinars (15)
Section
Business (126792)
Career Advice (1366)
Deals (18643)
Drug Delivery (76)
Drug Development (65414)
Employer Resources (95)
FDA (9803)
Job Trends (10044)
News (219463)
Policy (17523)
Tag
2027 Biotech Bay Standard (2)
2027 Pharm Country Standard (2)
Academia (2662)
Academic (1)
Accelerated approval (28)
Adcomms (22)
Allergies (85)
Alliances (37008)
ALS (154)
Alzheimer's disease (1510)
Antibody-drug conjugate (ADC) (314)
Approvals (9984)
Artificial intelligence (402)
Autoimmune disease (143)
Automation (26)
Bankruptcy (116)
Best Places to Work (8058)
BIOSECURE Act (15)
Biosimilars (112)
Biotechnology (126)
Bladder cancer (135)
Brain cancer (57)
Breast cancer (557)
Cancer (4553)
Cardiovascular disease (262)
Career advice (1154)
Career pathing (27)
CAR-T (298)
CDC (26)
Cell therapy (815)
Cervical cancer (28)
Clinical research (54301)
Collaboration (1505)
Company closure (3)
Compensation (398)
Complete response letters (35)
COVID-19 (2257)
CRISPR (87)
C-suite (582)
Cystic fibrosis (124)
Data (5246)
Decentralized trials (2)
Denatured (17)
Depression (87)
Diabetes (319)
Diagnostics (4590)
Digital health (22)
Diversity (7)
Diversity, equity & inclusion (25)
Drug discovery (228)
Drug pricing (99)
Drug shortages (7)
Duchenne muscular dystrophy (167)
Earnings (48744)
Editorial (40)
Employer branding (14)
Employer resources (85)
Events (66426)
Executive appointments (668)
FDA (12029)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (8)
Frontotemporal dementia (20)
Funding (1120)
Gene editing (181)
Generative AI (35)
Gene therapy (571)
GLP-1 (591)
Government (2743)
Grass and pollen (3)
Guidances (326)
Healthcare (12409)
HIV (42)
Huntington's disease (31)
IgA nephropathy (57)
Immunology and inflammation (191)
Immuno-oncology (52)
Indications (80)
Infectious disease (2451)
Inflammatory bowel disease (145)
Inflation Reduction Act (8)
Influenza (86)
Intellectual property (177)
Interviews (279)
IPO (9131)
IRA (35)
Job creations (2300)
Job search strategy (978)
JPM (43)
Kidney cancer (16)
Labor market (57)
Layoffs (376)
Leadership (16)
Legal (2833)
Liver cancer (80)
Longevity (12)
Lung cancer (667)
Lymphoma (381)
Machine learning (37)
Management (29)
Manufacturing (585)
MASH (120)
Medical device (6558)
Medtech (6590)
Mergers & acquisitions (10229)
Metabolic disorders (737)
Multiple sclerosis (137)
NASH (12)
Neurodegenerative disease (269)
Neuropsychiatric disorders (50)
Neuroscience (2492)
Neurotech (1)
NextGen: Class of 2026 (3814)
Non-profit (3687)
Now hiring (46)
Obesity (284)
Opinion (204)
Ovarian cancer (156)
Pain (125)
Pancreatic cancer (199)
Parkinson's disease (256)
Partnered (28)
Patents (336)
Patient recruitment (374)
Peanut (37)
People (37939)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (18175)
Phase 2 (23932)
Phase 3 (17238)
Pipeline (4136)
Policy (183)
Postmarket research (2037)
Preclinical (8820)
Press Release (70)
Prostate cancer (215)
Psychedelics (35)
Radiopharmaceuticals (225)
Rare diseases (677)
Real estate (4136)
Recruiting (38)
Regulatory (15076)
Reports (34)
Research institute (2623)
Resumes & cover letters (195)
Rett syndrome (18)
RNA editing (12)
RSV (51)
Schizophrenia (103)
Series A (165)
Series B (121)
Service/supplier (11)
Sickle cell disease (104)
Special edition (21)
Spinal muscular atrophy (145)
Sponsored (37)
Startups (2522)
State (1)
Stomach cancer (16)
Supply chain (54)
Tariffs (43)
The Weekly (55)
Vaccines (791)
Venture capital (53)
Weight loss (154)
Women's health (51)
Worklife (8)
Date
Last 7 days (363)
Last 30 days (1284)
Last 365 days (21437)
2026 (1869)
2025 (21863)
2024 (25611)
2023 (29317)
2022 (39497)
2021 (41608)
2020 (37686)
2019 (30087)
2018 (22706)
2017 (22208)
2016 (21834)
2015 (25892)
2014 (19529)
2013 (17229)
2012 (17343)
2011 (17837)
2010 (16513)
Location
Africa (598)
Alabama (76)
Alaska (5)
Arizona (148)
Arkansas (5)
Asia (30960)
Australia (5952)
California (7702)
Canada (2258)
China (925)
Colorado (300)
Connecticut (313)
Delaware (240)
Europe (70876)
Florida (1126)
Georgia (224)
Hawaii (2)
Idaho (35)
Illinois (549)
India (47)
Indiana (344)
Iowa (19)
Japan (363)
Kansas (70)
Kentucky (23)
Louisiana (16)
Maine (68)
Maryland (1003)
Massachusetts (5801)
Michigan (224)
Minnesota (304)
Mississippi (3)
Missouri (81)
Montana (22)
Nebraska (16)
Nevada (71)
New Hampshire (32)
New Jersey (2247)
New Mexico (27)
New York (2217)
North Carolina (1110)
North Dakota (9)
Northern California (3783)
Ohio (242)
Oklahoma (14)
Oregon (20)
Pennsylvania (1518)
Puerto Rico (8)
Rhode Island (33)
South America (675)
South Carolina (25)
Southern California (2987)
Tennessee (94)
Texas (1300)
United States (27847)
Utah (203)
Vermont (1)
Virginia (184)
Washington D.C. (57)
Washington State (740)
West Virginia (2)
Wisconsin (79)
Wyoming (1)
482,344 Results for "invitro cell research llc.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
February 3, 2026
·
2 min read
Press Releases
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
January 13, 2026
·
7 min read
Press Releases
acCELLerate Facilitates Custom Cell Banking Solutions for Pharmaceutical and Biotechnology Research with ATCC Authenticated Cell Lines
November 10, 2025
·
1 min read
Business
Stem Cell Specialist PrimeGen Takes SPAC Track to Nasdaq
The SPAC agreement values PrimeGen US at $1.5 billion in equity and gives it capital to advance its pre-clinical triple-activated mesenchymal stem cell pipeline into the clinic.
February 5, 2026
·
1 min read
·
Tristan Manalac
Cell therapy
After Cell Therapy Retreat, Novo Offloads Technologies in Deepened Aspect Pact
Novo Nordisk pulled back from cell therapies last October, scrapping development of a type 1 diabetes therapy and laying off most employees working on this modality.
January 21, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Maryland Stem Cell Research Fund Awards $4.7 million to Support Innovations in Stem Cell Research
October 3, 2025
·
4 min read
Press Releases
Hope Biosciences Research Foundation Reports Promising Phase II Trial Results for Stem Cell Therapy in Parkinson’s Disease
December 23, 2025
·
3 min read
Press Releases
New Research Highlights Syntax Bio’s Platform for Simple Yet Powerful Programming of Human Stem Cells
December 9, 2025
·
3 min read
Press Releases
PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell
January 9, 2026
·
5 min read
China
AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma
AstraZeneca has risen as one of pharma’s most prolific investors in China, including a $630 million pledge last week for full rights to AbelZeta’s cell therapy for cancer.
January 29, 2026
·
1 min read
·
Tristan Manalac
1 of 48,235
Next
